Amphastar Pharmaceuticals Inc. (AMPH)
NASDAQ · Healthcare
Amphastar Pharmaceuticals Inc. Price to FCF Ratio 2014–2026
Price to free cash flow (P/FCF) ratio for Amphastar Pharmaceuticals Inc. (AMPH): market cap divided by trailing twelve-month free cash flow. As of March 31, 2026 it is 7.51.
From: 06/30/2014To: 03/31/2026
Stock Price
TTM Free Cash Flow
Price to FCF
Amphastar Pharmaceuticals Inc. Price to FCF Ratio — FAQ
Amphastar Pharmaceuticals Inc. (AMPH) price to fcf ratio over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMPH's price to fcf ratio history?
The chart and table above show Amphastar Pharmaceuticals Inc.'s price to fcf ratio by year and by quarter, including the growth rate.